$HTLD
HEARTLAND EXPRESS INC

2023 Q4 Form 10-Q Financial Statement

#000079923323000049 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $275.3M $295.0M
YoY Change -22.42% 7.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $223.8M $235.2M
YoY Change -14.89% 19.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $51.12M $51.10M
YoY Change 0.95% 46.89%
% of Gross Profit
Operating Expenses $289.9M $303.6M
YoY Change -12.92% 23.38%
Operating Profit -$7.440M
YoY Change -121.42%
Interest Expense -$5.630M $6.067M
YoY Change -1.05% -435.56%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $5.075M -$13.23M
YoY Change -75.21% -140.17%
Income Tax -$20.00K -$2.528M
% Of Pretax Income -0.39%
Net Earnings $5.095M -$10.70M
YoY Change -67.11% -143.84%
Net Earnings / Revenue 1.85% -3.63%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share $0.06 -$0.14
COMMON SHARES
Basic Shares Outstanding 79.03M shares 79.03M shares
Diluted Shares Outstanding 79.10M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.12M $20.10M
YoY Change -43.14% -68.99%
Cash & Equivalents $28.12M $20.10M
Short-Term Investments
Other Short-Term Assets $28.25M $20.74M
YoY Change 8.37% -45.83%
Inventory
Prepaid Expenses
Receivables $102.7M $113.9M
Other Receivables $10.16M $15.40M
Total Short-Term Assets $169.3M $182.1M
YoY Change -26.33% -31.59%
LONG-TERM ASSETS
Property, Plant & Equipment $902.8M $926.1M
YoY Change -7.24% -6.68%
Goodwill $322.6M $322.6M
YoY Change 0.6% 1.83%
Intangibles $98.54M $99.80M
YoY Change -4.98% -3.39%
Long-Term Investments
YoY Change
Other Assets $16.45M $31.98M
YoY Change -17.33% 39.46%
Total Long-Term Assets $1.340B $1.393B
YoY Change -6.9% -2.92%
TOTAL ASSETS
Total Short-Term Assets $169.3M $182.1M
Total Long-Term Assets $1.340B $1.393B
Total Assets $1.510B $1.576B
YoY Change -9.57% -7.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.78M $60.30M
YoY Change -39.76% 1.43%
Accrued Expenses $76.40M $72.70M
YoY Change -4.62% -8.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $9.303M $9.131M
YoY Change 363.07% -48.26%
Total Short-Term Liabilities $123.5M $142.1M
YoY Change -21.23% -11.08%
LONG-TERM LIABILITIES
Long-Term Debt $290.7M $334.8M
YoY Change -27.16% -25.16%
Other Long-Term Liabilities $41.09M $42.20M
YoY Change -18.91% -22.55%
Total Long-Term Liabilities $331.8M $572.3M
YoY Change -49.52% 14.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $123.5M $142.1M
Total Long-Term Liabilities $331.8M $572.3M
Total Liabilities $644.4M $714.4M
YoY Change -20.84% -17.0%
SHAREHOLDERS EQUITY
Retained Earnings $1.060B $1.057B
YoY Change 0.8% 1.82%
Common Stock $5.434M $5.168M
YoY Change 7.14% -0.84%
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.3M $200.6M
YoY Change -0.48% -0.71%
Treasury Stock Shares
Shareholders Equity $865.3M $861.1M
YoY Change
Total Liabilities & Shareholders Equity $1.510B $1.576B
YoY Change -9.57% -7.41%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $5.095M -$10.70M
YoY Change -67.11% -143.84%
Depreciation, Depletion And Amortization $51.12M $51.10M
YoY Change 0.95% 46.89%
Cash From Operating Activities $40.77M $27.20M
YoY Change -50.38% -49.67%
INVESTING ACTIVITIES
Capital Expenditures $31.70M $68.90M
YoY Change -53.9% -267.01%
Acquisitions
YoY Change
Other Investing Activities $45.73M $20.70M
YoY Change 69.72% -103.85%
Cash From Investing Activities $13.93M -$48.00M
YoY Change -133.33% -91.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -47.39M -6.800M
YoY Change -14.86% -101.63%
NET CHANGE
Cash From Operating Activities 40.77M 27.20M
Cash From Investing Activities 13.93M -48.00M
Cash From Financing Activities -47.39M -6.800M
Net Change In Cash 7.310M -27.60M
YoY Change -147.77% -74.19%
FREE CASH FLOW
Cash From Operating Activities $40.77M $27.20M
Capital Expenditures $31.70M $68.90M
Free Cash Flow $9.071M -$41.70M
YoY Change -32.37% -143.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1580000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
127000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2023Q3 htld Restricted Stock Shares Remaining Available
RestrictedStockSharesRemainingAvailable
486531 shares
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-100000 usd
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1100000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191 rate
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259 rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.345 rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.265 rate
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
872937000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10703000 usd
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1581000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
477000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
861130000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
16775000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1579000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
230000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
742528000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
76906000 usd
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1579000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
47000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
817902000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
24415000 usd
CY2022Q3 us-gaap Dividends Common Stock
DividendsCommonStock
1580000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
152000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
840889000 usd
htld Net Income2
NetIncome2
9680000 usd
htld Net Income2
NetIncome2
118095000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
147919000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82408000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
11903000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2171000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
928000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
504000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
806000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
90000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
15873000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
92806000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-25874000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3200000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4604000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
655000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25176000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1725000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-12408000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7668000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124451000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
112550000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
94660000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
146376000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176861000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91818000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
675852000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-382000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
159000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81819000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-621453000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3161000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3157000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
447343000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
213000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
69887000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73261000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
414916000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-30629000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-93987000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64478000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173767000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33849000 usd
us-gaap Interest Paid Net
InterestPaidNet
16779000 usd
us-gaap Interest Paid Net
InterestPaidNet
989000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
29138000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
32695000 usd
htld Fair Value Of Revenue Equipment Traded
FairValueOfRevenueEquipmentTraded
0 usd
htld Fair Value Of Revenue Equipment Traded
FairValueOfRevenueEquipmentTraded
428000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
22270000 usd
htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
2089000 usd
htld Common Stock Dividends Declared In Accounts Payable
CommonStockDividendsDeclaredInAccountsPayable
1581000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20101000 usd
CY2023Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
299000 usd
CY2023Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
13449000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33849000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9680000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79069000 shares
CY2022Q4 us-gaap Goodwill
Goodwill
320700000 usd
CY2023Q3 htld Goodwill Acquired During Period Cfi
GoodwillAcquiredDuringPeriodCFI
1900000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 htld Net Income Loss Eps
NetIncomeLossEPS
-10703000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79021000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q3 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82000 shares
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10703000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79103000 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 htld Net Income Loss Eps
NetIncomeLossEPS
24415000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78937000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022Q3 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
37000 shares
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
24415000 usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78974000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
htld Net Income Loss Eps
NetIncomeLossEPS
9680000 usd
htld Net Income Loss Eps
NetIncomeLossEPS
9680000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79003000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
htld Net Income Loss Eps
NetIncomeLossEPS
118095000 usd
htld Net Income Loss Eps
NetIncomeLossEPS
118095000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78933000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.50
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 usd
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
29000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
118095000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78962000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
CY2023Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
6600000 shares
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2022Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4700000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4700000 usd
CY2011Q3 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
900000 shares
CY2021Q2 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
600000 shares
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
200000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
500000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
htld Term Sofr One Month Spread
TermSOFROneMonthSpread
0.011 rate
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
800000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y7M6D
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
95000.0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.23
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
15000.0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.17
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
80000.0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.24
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
25000.0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
17.21
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
22300 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.76
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2800 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.30
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44500 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.60
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
40100 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
93300 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
53400 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
80000.0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.24
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
14000.0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
50300 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
19800 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
15.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44500 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.60
CY2022Q3 htld Unsecured Credit Facility
UnsecuredCreditFacility
550000000 usd
CY2022Q3 htld Term Facility
TermFacility
450000000 usd
CY2022Q3 htld Revolving Facility
RevolvingFacility
100000000 usd
CY2022Q3 htld Available Issuance Of Line Of Credit
AvailableIssuanceOfLineOfCredit
50000000 usd
CY2022Q3 htld Swingline Facility
SwinglineFacility
20000000 usd
CY2022Q3 htld Uncommitted Accordion Feature
UncommittedAccordionFeature
275000000 usd
htld Max Annual Dividend
MaxAnnualDividend
10000000 usd
htld Debt Instrument Covenant Distributions Max Leverage Ratio
DebtInstrumentCovenantDistributionsMaxLeverageRatio
2.5
htld Debt Instrument Covenant Maximum Net Leverage Ratio
DebtInstrumentCovenantMaximumNetLeverageRatio
2.75
htld Debt Instrument Covenant Minimum Interest Coverage Ratio
DebtInstrumentCovenantMinimumInterestCoverageRatio
3
htld Applicable Margin Base
ApplicableMarginBase
0.0100 rate
CY2023Q3 htld Outstanding Debt On Term Facility
OutstandingDebtOnTermFacility
315000000 usd
CY2023Q3 htld Outstanding Debt On Revolving Facility
OutstandingDebtOnRevolvingFacility
0 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
12000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
88000000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 htld Weighted Average Interest Rate Credit Facility
WeightedAverageInterestRateCreditFacility
0.069 rate
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1500000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2022Q2 htld Business Combination Long Term Debt
BusinessCombinationLongTermDebt
46800000 usd
CY2023Q3 htld Business Combination Long Term Debt
BusinessCombinationLongTermDebt
30400000 usd
CY2023Q3 htld Debt
Debt
8200000 usd
CY2023Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.044 rate
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 htld Finance Lease Obligations
FinanceLeaseObligations
22200000 usd
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.039 rate
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q3 htld Right Of Use Asset Associated With The Leased Terminal Facility
RightOfUseAssetAssociatedWithTheLeasedTerminalFacility
1500000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 htld Right Of Use Operating Lease Assets
RightOfUseOperatingLeaseAssets
10000000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038 rate
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2663000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
3899000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6000000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
8201000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3003000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
7481000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
150000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3894000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11816000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
23475000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
363000 usd
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
1263000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11453000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
22212000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7520000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7282000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3933000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
14930000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5700000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4500000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-100000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 usd
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1100000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 usd
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-100000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5744000 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
259000 usd
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
391000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5612000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
17700000 usd
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000799233-23-000049-index-headers.html Edgar Link pending
0000799233-23-000049-index.html Edgar Link pending
0000799233-23-000049.txt Edgar Link pending
0000799233-23-000049-xbrl.zip Edgar Link pending
exhibit3112023q3.htm Edgar Link pending
exhibit3122023q3.htm Edgar Link pending
exhibit3212023q3.htm Edgar Link pending
exhibit3222023q3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
htld-20230930.htm Edgar Link pending
htld-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
htld-20230930_def.xml Edgar Link unprocessable
htld-20230930_pre.xml Edgar Link unprocessable
htld-20230930_htm.xml Edgar Link completed
htld-20230930_cal.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
htld-20230930_lab.xml Edgar Link unprocessable